Lai Wang, Global Head of R&D at BeOne Medicines Ltd. (ONC), sold 3,294 shares at $266.40 ($863K) on 2025-06-16, disclosed to the SEC on 2025-06-18.
Open-market sale of $863k ONC by Global Head of R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $266.40 | 1,177 | $314K | 36.3% |
| 2 | $266.40 | 1,177 | $314K | 36.3% |
| 3 | $251.37 | 470 | $118K | 13.7% |
| 4 | $251.37 | 470 | $118K | 13.7% |
| Total | $262.11 avg | 3,294 | $863K | 100% |
| Filing → |
| ONC | SELL | 2026-06-15 | $197K | — | Filing → |
| ONC | SELL | 2026-06-10 | $368K | — | Filing → |
| ONC | SELL | 2025-09-11 | $1.8M | — | Filing → |